| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride channel activity | 2.31e-06 | 86 | 139 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 7.73e-06 | 103 | 139 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.08e-05 | 151 | 139 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.50e-05 | 50 | 139 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.74e-05 | 125 | 139 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 4.81e-05 | 2 | 139 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 4.81e-05 | 2 | 139 | 2 | GO:0003920 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 4.81e-05 | 2 | 139 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 5.23e-05 | 11 | 139 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.73e-04 | 16 | 139 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC2A9 SLCO2B1 SLC25A33 PKD1L1 SLC1A6 SLC66A1 SLC9C1 ATP6V1H ATP2C1 CLCNKA CLCA2 P2RX6 SV2A ATP2C2 SLC35E3 ANO3 SLC26A6 GABRA1 GABRA2 GABRA3 | 1.96e-04 | 1180 | 139 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.98e-04 | 171 | 139 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.49e-04 | 18 | 139 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF23 DYNC2H1 SRCAP BLM ATP6V1H ATP2C1 FBH1 RECQL5 ATP2C2 HFM1 AQR | 2.67e-04 | 441 | 139 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.95e-04 | 19 | 139 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | small GTPase binding | 4.22e-04 | 321 | 139 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC2A9 PKD1L1 SLC1A6 SLC9C1 ATP6V1H ATP2C1 CLCNKA CLCA2 P2RX6 ATP2C2 ANO3 SLC26A6 GABRA1 GABRA2 GABRA3 | 4.25e-04 | 793 | 139 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | GABA receptor activity | 4.61e-04 | 22 | 139 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.06e-04 | 262 | 139 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.00e-04 | 24 | 139 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | transporter activity | SLC2A9 SLCO2B1 SLC25A33 PKD1L1 SLC1A6 SLC66A1 SLC9C1 ATP6V1H ATP2C1 CLCNKA CLCA2 P2RX6 SV2A ATP2C2 SLC35E3 ANO3 SLC26A6 GABRA1 GABRA2 GABRA3 | 6.11e-04 | 1289 | 139 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 7.09e-04 | 6 | 139 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC2A9 PKD1L1 SLC1A6 SLC9C1 ATP6V1H ATP2C1 CLCNKA CLCA2 ATP2C2 ANO3 SLC26A6 GABRA1 GABRA2 GABRA3 | 8.37e-04 | 758 | 139 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | helicase activity | 8.44e-04 | 158 | 139 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 9.17e-04 | 62 | 139 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | GTPase binding | 9.56e-04 | 360 | 139 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF23 DYNC2H1 MYO10 SRCAP BLM ATP6V1H ATP2C1 FBH1 RECQL5 ATP2C2 HFM1 AQR | 1.23e-03 | 614 | 139 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | U1 snRNA binding | 1.31e-03 | 8 | 139 | 2 | GO:0030619 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | PKD1L1 SLC9C1 CLCNKA CLCA2 P2RX6 ANO3 SLC26A6 GABRA1 GABRA2 GABRA3 | 1.42e-03 | 459 | 139 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.96e-03 | 127 | 139 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.05e-03 | 77 | 139 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 2.09e-03 | 10 | 139 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.34e-03 | 193 | 139 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.54e-03 | 11 | 139 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.59e-03 | 197 | 139 | 6 | GO:0022834 | |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 1.35e-07 | 8 | 139 | 4 | GO:1990414 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.09e-05 | 112 | 139 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | chloride transport | 2.60e-05 | 128 | 139 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.49e-05 | 134 | 139 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.11e-05 | 153 | 139 | 7 | GO:0098656 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.84e-05 | 57 | 139 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | GMP reductase complex | 4.39e-05 | 2 | 139 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.84e-04 | 300 | 139 | 9 | GO:0008021 | |
| GeneOntologyCellularComponent | secretory vesicle | A2M DMXL2 AMPH ACLY HPSE PICALM CDC37L1 IQGAP1 PIKFYVE ATP6V1H ATP2C1 VPS33B OTOF ASAH1 SV2A NBEAL2 NGF CD58 PLCB2 GABRA2 | 2.20e-04 | 1246 | 139 | 20 | GO:0099503 |
| GeneOntologyCellularComponent | lateral element | 2.58e-04 | 19 | 139 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.58e-04 | 19 | 139 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.97e-04 | 320 | 139 | 9 | GO:0070382 | |
| GeneOntologyCellularComponent | GABA receptor complex | 3.51e-04 | 21 | 139 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | intercellular bridge | 4.13e-04 | 94 | 139 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | meiotic cohesin complex | 9.02e-04 | 7 | 139 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.27e-03 | 179 | 139 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.27e-03 | 179 | 139 | 6 | GO:0030672 | |
| Domain | GABAAa_rcpt | 7.27e-06 | 6 | 135 | 3 | IPR001390 | |
| Domain | P-type_ATPase_IIA_PMR1 | 5.19e-05 | 2 | 135 | 2 | IPR006413 | |
| Domain | GMPR | 5.19e-05 | 2 | 135 | 2 | IPR005993 | |
| Domain | Rad21/Rec8_C_eu | 1.55e-04 | 3 | 135 | 2 | IPR006909 | |
| Domain | Rad21_Rec8_N | 1.55e-04 | 3 | 135 | 2 | IPR006910 | |
| Domain | Rad21_Rec8_N | 1.55e-04 | 3 | 135 | 2 | PF04825 | |
| Domain | Rad21_Rec8 | 1.55e-04 | 3 | 135 | 2 | PF04824 | |
| Domain | Rad21/Rec8_C | 1.55e-04 | 3 | 135 | 2 | IPR023093 | |
| Domain | - | 1.55e-04 | 3 | 135 | 2 | 1.10.10.580 | |
| Domain | IMPDH | 3.08e-04 | 4 | 135 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 3.08e-04 | 4 | 135 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 3.08e-04 | 4 | 135 | 2 | PS00487 | |
| Domain | RecQ_Zn_bind | 3.08e-04 | 4 | 135 | 2 | PF16124 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 3.08e-04 | 4 | 135 | 2 | IPR015875 | |
| Domain | RecQ_Zn-bd | 3.08e-04 | 4 | 135 | 2 | IPR032284 | |
| Domain | DNA_helicase_ATP-dep_RecQ | 5.11e-04 | 5 | 135 | 2 | IPR004589 | |
| Domain | GABAA/Glycine_rcpt | 5.88e-04 | 23 | 135 | 3 | IPR006028 | |
| Domain | WHTH_DNA-bd_dom | 1.91e-03 | 242 | 135 | 7 | IPR011991 | |
| Domain | ELM2_dom | 3.84e-03 | 13 | 135 | 2 | IPR000949 | |
| Domain | ELM2 | 3.84e-03 | 13 | 135 | 2 | PF01448 | |
| Domain | ELM2 | 3.84e-03 | 13 | 135 | 2 | PS51156 | |
| Domain | ELM2 | 3.84e-03 | 13 | 135 | 2 | SM01189 | |
| Domain | IQ_motif_EF-hand-BS | 4.13e-03 | 90 | 135 | 4 | IPR000048 | |
| Domain | Neurotransmitter_ion_chnl_CS | 4.20e-03 | 45 | 135 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 4.47e-03 | 46 | 135 | 3 | PF02932 | |
| Domain | IQ | 4.64e-03 | 93 | 135 | 4 | PS50096 | |
| Domain | Neurotrans-gated_channel_TM | 4.75e-03 | 47 | 135 | 3 | IPR006029 | |
| Domain | - | 4.75e-03 | 47 | 135 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.75e-03 | 47 | 135 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.75e-03 | 47 | 135 | 3 | PS00236 | |
| Domain | Neur_channel | 4.75e-03 | 47 | 135 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.75e-03 | 47 | 135 | 3 | IPR006202 | |
| Domain | ATPase_P-typ_TM_dom | 5.82e-03 | 16 | 135 | 2 | IPR023298 | |
| Domain | - | 5.82e-03 | 16 | 135 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.57e-03 | 17 | 135 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.57e-03 | 17 | 135 | 2 | PF00689 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 3.36e-05 | 9 | 106 | 3 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.77e-05 | 10 | 106 | 3 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.77e-05 | 10 | 106 | 3 | MM1401 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.06e-05 | 183 | 106 | 8 | M997 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 15017002 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 16835366 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 15304513 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 1356407 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 26518133 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 25865415 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 25080596 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 2.49e-07 | 4 | 139 | 3 | 18821008 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 6.21e-07 | 5 | 139 | 3 | 30104684 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KIF23 NSD1 SRCAP FOXJ3 MIER1 BLM FSIP2 SETDB2 BRCA1 RECQL5 SPEN DNMT1 RAD21 | 1.09e-06 | 608 | 139 | 13 | 36089195 |
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.24e-06 | 6 | 139 | 3 | 15033447 | |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 20457185 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 2.16e-06 | 7 | 139 | 3 | 20843900 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 35228700 | ||
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 16101898 | ||
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 8175718 | ||
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 11528422 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 7.34e-06 | 10 | 139 | 3 | 21789198 | |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 1.01e-05 | 11 | 139 | 3 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 1.01e-05 | 11 | 139 | 3 | 38894703 | |
| Pubmed | Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | 1.16e-05 | 35 | 139 | 4 | 37758766 | |
| Pubmed | KIF23 ACLY NSD1 PRPF8 IQGAP1 BLM MCM3AP SNRNP70 SPEN AQR DNMT1 RAD21 | 1.32e-05 | 653 | 139 | 12 | 22586326 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 1.34e-05 | 12 | 139 | 3 | 2561974 | |
| Pubmed | KIF23 MUC16 CEMIP2 BLM PCF11 ARFRP1 BRCA1 TENM3 TJAP1 SPEN HNRNPLL ANO3 DNMT1 | 1.54e-05 | 777 | 139 | 13 | 35844135 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22763624 | ||
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 1.59e-05 | 2 | 139 | 2 | 28618103 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24379826 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23147414 | ||
| Pubmed | α2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations. | 1.59e-05 | 2 | 139 | 2 | 23109109 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22666188 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8391122 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18973555 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 1.59e-05 | 2 | 139 | 2 | 18202657 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16332677 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9655866 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32569620 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 1.59e-05 | 2 | 139 | 2 | 11021797 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26345926 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18085262 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24553732 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21073549 | ||
| Pubmed | BRCA1 affects global DNA methylation through regulation of DNMT1. | 1.59e-05 | 2 | 139 | 2 | 20820192 | |
| Pubmed | Comparative mapping on the mouse X chromosome defines a myotubular myopathy equivalent region. | 1.59e-05 | 2 | 139 | 2 | 8678976 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 1.59e-05 | 2 | 139 | 2 | 15341600 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21056629 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 218932 | ||
| Pubmed | 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter. | 1.59e-05 | 2 | 139 | 2 | 28564603 | |
| Pubmed | Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes. | 1.59e-05 | 2 | 139 | 2 | 34556815 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23067879 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 1.59e-05 | 2 | 139 | 2 | 26973458 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12009299 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.59e-05 | 361 | 139 | 9 | 26167880 | |
| Pubmed | ACLY PRPF8 PICALM EXOC8 IQGAP1 HAUS8 ATP6V1H VPS33B LTN1 AQR RAD21 | 1.67e-05 | 560 | 139 | 11 | 35241646 | |
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 22569571 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 22640814 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | PRPF8 PICALM IQGAP1 BLM PCF11 VPS33B XPO6 SNRNP70 HNRNPLL AQR RAD21 | 2.38e-05 | 582 | 139 | 11 | 20467437 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KIF23 NOP56 RPAP3 ACLY ACOT7 SRCAP PRPF8 ANKRD27 IQGAP1 BLM ADPRS VPS33B MCM3AP RECQL5 LTN1 AQR DNMT1 | 3.01e-05 | 1353 | 139 | 17 | 29467282 |
| Pubmed | CNTN4 DMXL2 DYNC2H1 SLCO2B1 CTIF PCF11 PIKFYVE ATP2C1 LTN1 ZNF518B | 3.12e-05 | 493 | 139 | 10 | 15368895 | |
| Pubmed | 4.05e-05 | 407 | 139 | 9 | 12693553 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 4.21e-05 | 157 | 139 | 6 | 30686591 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29860064 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 14612409 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 20032382 | ||
| Pubmed | Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells. | 4.75e-05 | 3 | 139 | 2 | 25084169 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 27128218 | ||
| Pubmed | FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres. | 4.75e-05 | 3 | 139 | 2 | 28673972 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 26689987 | ||
| Pubmed | RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase. | 4.75e-05 | 3 | 139 | 2 | 29415885 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 31285763 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 32376074 | ||
| Pubmed | BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution. | 4.75e-05 | 3 | 139 | 2 | 38266639 | |
| Pubmed | RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway. | 4.75e-05 | 3 | 139 | 2 | 25520194 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 14715656 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 18063661 | ||
| Pubmed | GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. | 4.75e-05 | 3 | 139 | 2 | 18818659 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 12646176 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 17713555 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 27871469 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 19205873 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23897429 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29023704 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 15254090 | ||
| Pubmed | Candidate genes for alcohol dependence: A genetic association study from India. | 4.75e-05 | 3 | 139 | 2 | 28361821 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 34433078 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 7686585 | ||
| Pubmed | Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis. | 4.75e-05 | 3 | 139 | 2 | 19196664 | |
| Pubmed | Store-independent activation of Orai1 by SPCA2 in mammary tumors. | 4.75e-05 | 3 | 139 | 2 | 20887894 | |
| Pubmed | 4.88e-05 | 18 | 139 | 3 | 19078961 | ||
| Pubmed | 4.88e-05 | 18 | 139 | 3 | 18985723 | ||
| Pubmed | A2M KIF23 NOP56 SRCAP MIER1 PHKB HAUS8 ATP6V1H BRCA1 RECQL5 SPEN | 6.01e-05 | 645 | 139 | 11 | 25281560 | |
| Pubmed | 6.65e-05 | 105 | 139 | 5 | 9628581 | ||
| Pubmed | 6.95e-05 | 250 | 139 | 7 | 33536335 | ||
| Pubmed | 7.88e-05 | 21 | 139 | 3 | 25708312 | ||
| Pubmed | 9.10e-05 | 22 | 139 | 3 | 35245678 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | NAA60 NOP56 DOCK9 FOXJ3 TERT PICALM HAUS8 ATP2C1 FBH1 ASAH1 TJAP1 HNRNPLL DNMT1 | 9.15e-05 | 925 | 139 | 13 | 28986522 |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 36277219 | ||
| Pubmed | UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. | 9.47e-05 | 4 | 139 | 2 | 19943104 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.24e-04 | 19 | 94 | 3 | 563 | |
| GeneFamily | RecQ like helicases | 2.65e-04 | 5 | 94 | 2 | 1049 | |
| GeneFamily | ATPases Ca2+ transporting | 9.40e-04 | 9 | 94 | 2 | 1209 | |
| GeneFamily | Solute carriers | 1.05e-03 | 395 | 94 | 8 | 752 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 AMPH KIF23 MYO10 DOCK9 SPC25 CTIF FOXJ3 PICALM BLM PCF11 PIKFYVE ATP6V1H ATP2C1 BRCA1 XPO6 LTN1 ALCAM SPEN AQR | 2.46e-08 | 856 | 138 | 20 | M4500 |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.20e-06 | 200 | 138 | 9 | M6621 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-06 | 189 | 139 | 7 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-06 | 191 | 139 | 7 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 200 | 139 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 166 | 139 | 6 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 166 | 139 | 6 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 167 | 139 | 6 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 167 | 139 | 6 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-05 | 169 | 139 | 6 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.74e-05 | 173 | 139 | 6 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 174 | 139 | 6 | a79ebb01a5849c314e02594a9c95009dbb03cb8c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-05 | 175 | 139 | 6 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 177 | 139 | 6 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-05 | 184 | 139 | 6 | bc0dfe29337f02594e7e0092c9e47dda94b45ad5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 186 | 139 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 187 | 139 | 6 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 187 | 139 | 6 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 187 | 139 | 6 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 113 | 139 | 5 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 190 | 139 | 6 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 190 | 139 | 6 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 190 | 139 | 6 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 190 | 139 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 190 | 139 | 6 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 190 | 139 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.04e-05 | 191 | 139 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 3.04e-05 | 191 | 139 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.13e-05 | 192 | 139 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 193 | 139 | 6 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-05 | 193 | 139 | 6 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-05 | 193 | 139 | 6 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.22e-05 | 193 | 139 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 195 | 139 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 3.42e-05 | 195 | 139 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.42e-05 | 195 | 139 | 6 | 3c5b7cce4a1c4b28fa3b657cce4148669a59e55e | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM5|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.42e-05 | 195 | 139 | 6 | 6d768454ed630e586431535400507074eea76dd1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.83e-05 | 199 | 139 | 6 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.83e-05 | 199 | 139 | 6 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 3.83e-05 | 199 | 139 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 200 | 139 | 6 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 200 | 139 | 6 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 3.93e-05 | 200 | 139 | 6 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 3.93e-05 | 200 | 139 | 6 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 3.93e-05 | 200 | 139 | 6 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.93e-05 | 200 | 139 | 6 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 200 | 139 | 6 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 3.93e-05 | 200 | 139 | 6 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | (52)_cycling_DCs|World / shred on Cell_type and subtype | 4.05e-05 | 201 | 139 | 6 | ad2d25d84345fdd593065516a05c5c2b5429eac0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(Neuron.Slc17a6.Nts)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.75e-05 | 67 | 139 | 4 | bc06a697f47b60c43e238f8c6803a1b061f22550 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(Neuron.Slc17a6.Nts)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.75e-05 | 67 | 139 | 4 | 50acd69659f6d827868dc48bfb00af8634a8b4c7 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.81e-05 | 136 | 139 | 5 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-05 | 136 | 139 | 5 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.08e-05 | 141 | 139 | 5 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 149 | 139 | 5 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 1.22e-04 | 154 | 139 | 5 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 155 | 139 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 155 | 139 | 5 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 1.26e-04 | 155 | 139 | 5 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 155 | 139 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 157 | 139 | 5 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 157 | 139 | 5 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 161 | 139 | 5 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.60e-04 | 163 | 139 | 5 | 80bc3732afd8501938753120b8403098c7c5e928 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.60e-04 | 163 | 139 | 5 | 67551fefe22bd5b8178fa248fed2a6c17b19fb0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 164 | 139 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 164 | 139 | 5 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 168 | 139 | 5 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 169 | 139 | 5 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 169 | 139 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-04 | 171 | 139 | 5 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-04 | 172 | 139 | 5 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 172 | 139 | 5 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 172 | 139 | 5 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 139 | 5 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 173 | 139 | 5 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.16e-04 | 174 | 139 | 5 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 174 | 139 | 5 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 174 | 139 | 5 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-04 | 178 | 139 | 5 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 178 | 139 | 5 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.46e-04 | 179 | 139 | 5 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.46e-04 | 179 | 139 | 5 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-04 | 179 | 139 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.46e-04 | 179 | 139 | 5 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.46e-04 | 179 | 139 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-04 | 180 | 139 | 5 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 180 | 139 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 2.53e-04 | 180 | 139 | 5 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.66e-04 | 182 | 139 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 182 | 139 | 5 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 183 | 139 | 5 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.73e-04 | 183 | 139 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | severe-multiplets|severe / disease stage, cell group and cell class | 2.73e-04 | 183 | 139 | 5 | 78af8df48f0fe49ac37ccec0ad7b2993883b1148 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 184 | 139 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 2.80e-04 | 184 | 139 | 5 | 057c6c2f570914fa4af84682589a86b61547d6c9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-04 | 184 | 139 | 5 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| Computational | Genes in the cancer module 396. | 9.97e-05 | 12 | 85 | 3 | MODULE_396 | |
| Computational | Genes in the cancer module 141. | 2.48e-04 | 16 | 85 | 3 | MODULE_141 | |
| Drug | Zolpidem | 2.18e-07 | 3 | 138 | 3 | DB00425 | |
| Drug | Flumazenil | 8.68e-07 | 4 | 138 | 3 | DB01205 | |
| Drug | Eszopiclone | 2.16e-06 | 5 | 138 | 3 | DB00402 | |
| Drug | Zopiclone | 2.16e-06 | 5 | 138 | 3 | DB01198 | |
| Drug | Lorazepam | 2.16e-06 | 5 | 138 | 3 | ctd:D008140 | |
| Drug | picrotoxinine | 2.74e-06 | 65 | 138 | 6 | CID000004816 | |
| Drug | Meprobamate | 4.30e-06 | 6 | 138 | 3 | DB00371 | |
| Drug | sodium | NPR1 SLC2A9 SLCO2B1 PRPF8 SLC1A6 BLM ATP6V1H ATP2C1 CLCNKA P2RX6 ATP2C2 NGF GMPR PLCB2 POLG2 GABRA1 DNMT1 GABRA2 GABRA3 | 4.38e-06 | 944 | 138 | 19 | CID000000923 |
| Drug | Quazepam | 7.49e-06 | 7 | 138 | 3 | DB01589 | |
| Drug | Adinazolam | 1.19e-05 | 8 | 138 | 3 | DB00546 | |
| Drug | Fludiazepam | 1.19e-05 | 8 | 138 | 3 | DB01567 | |
| Drug | Clotiazepam | 1.19e-05 | 8 | 138 | 3 | DB01559 | |
| Drug | Cinolazepam | 1.19e-05 | 8 | 138 | 3 | DB01594 | |
| Drug | Prazepam | 1.19e-05 | 8 | 138 | 3 | DB01588 | |
| Drug | Estazolam | 1.19e-05 | 8 | 138 | 3 | DB01215 | |
| Drug | Halazepam | 1.19e-05 | 8 | 138 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.19e-05 | 8 | 138 | 3 | ctd:C091518 | |
| Drug | Ethchlorvynol | 1.78e-05 | 9 | 138 | 3 | DB00189 | |
| Drug | Diazepam | 1.78e-05 | 9 | 138 | 3 | DB00829 | |
| Drug | tiotidine | 1.78e-05 | 9 | 138 | 3 | ctd:C023990 | |
| Drug | Secobarbital | 2.53e-05 | 10 | 138 | 3 | DB00418 | |
| Drug | Chlordiazepoxide | 2.53e-05 | 10 | 138 | 3 | DB00475 | |
| Drug | Metharbital | 2.53e-05 | 10 | 138 | 3 | DB00463 | |
| Drug | Pentobarbital | 2.53e-05 | 10 | 138 | 3 | DB00312 | |
| Drug | Talbutal | 2.53e-05 | 10 | 138 | 3 | DB00306 | |
| Drug | Clobazam | 2.53e-05 | 10 | 138 | 3 | DB00349 | |
| Drug | Butalbital | 2.53e-05 | 10 | 138 | 3 | DB00241 | |
| Drug | Butabarbital | 2.53e-05 | 10 | 138 | 3 | DB00237 | |
| Drug | Bromazepam | 2.53e-05 | 10 | 138 | 3 | DB01558 | |
| Drug | Barbituric acid derivative | 2.53e-05 | 10 | 138 | 3 | DB01496 | |
| Drug | Barbital | 2.53e-05 | 10 | 138 | 3 | DB01483 | |
| Drug | Hexobarbital | 2.53e-05 | 10 | 138 | 3 | DB01355 | |
| Drug | Aprobarbital | 2.53e-05 | 10 | 138 | 3 | DB01352 | |
| Drug | Amobarbital | 2.53e-05 | 10 | 138 | 3 | DB01351 | |
| Drug | Heptabarbital | 2.53e-05 | 10 | 138 | 3 | DB01354 | |
| Drug | Butethal | 2.53e-05 | 10 | 138 | 3 | DB01353 | |
| Drug | Methylphenobarbital | 2.53e-05 | 10 | 138 | 3 | DB00849 | |
| Drug | Oxazepam | 2.53e-05 | 10 | 138 | 3 | DB00842 | |
| Drug | Primidone | 2.53e-05 | 10 | 138 | 3 | DB00794 | |
| Drug | Midazolam | 2.53e-05 | 10 | 138 | 3 | DB00683 | |
| Drug | Flurazepam | 2.53e-05 | 10 | 138 | 3 | DB00690 | |
| Drug | Clonazepam | 2.53e-05 | 10 | 138 | 3 | DB01068 | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 3068_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 2514_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.08e-05 | 200 | 138 | 8 | 6789_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.08e-05 | 200 | 138 | 8 | 5270_UP | |
| Drug | 3-isothujone | 3.13e-05 | 30 | 138 | 4 | CID000011027 | |
| Drug | Thiopental | 3.47e-05 | 11 | 138 | 3 | DB00599 | |
| Drug | Alprazolam | 3.47e-05 | 11 | 138 | 3 | DB00404 | |
| Drug | Temazepam | 3.47e-05 | 11 | 138 | 3 | DB00231 | |
| Drug | Nitrazepam | 3.47e-05 | 11 | 138 | 3 | DB01595 | |
| Drug | Lorazepam | 3.47e-05 | 11 | 138 | 3 | DB00186 | |
| Drug | Phenobarbital | 3.47e-05 | 11 | 138 | 3 | DB01174 | |
| Drug | Triazolam | 3.47e-05 | 11 | 138 | 3 | DB00897 | |
| Drug | Clorazepate | 3.47e-05 | 11 | 138 | 3 | DB00628 | |
| Drug | 3-nitrofluoranthen-6-ol | 3.65e-05 | 2 | 138 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 3.65e-05 | 2 | 138 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 3.65e-05 | 2 | 138 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 3.65e-05 | 2 | 138 | 2 | CID000053229 | |
| Drug | AC1L25J4 | 3.65e-05 | 2 | 138 | 2 | CID000041328 | |
| Drug | 2-methylcarbazole | 3.65e-05 | 2 | 138 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 3.65e-05 | 2 | 138 | 2 | CID000165122 | |
| Drug | 2-nitrobenzofuran | 3.65e-05 | 2 | 138 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 3.65e-05 | 2 | 138 | 2 | CID000034321 | |
| Drug | 17alpha-estradiol | EPO NPR1 KIF23 HPSE TERT MIER1 IQGAP1 BLM PIKFYVE ARFRP1 BRCA1 CLCNKA CLCA2 NGF CD58 PLCB2 HSD3B2 GABRA1 DNMT1 GABRA2 GABRA3 | 3.83e-05 | 1303 | 138 | 21 | CID000000450 |
| Drug | 3,4,5,3',4'-pentachlorobiphenyl | IGSF8 A2M RALGDS NPR1 AMPH SLCO2B1 SPC25 ACOT7 ESM1 ADAMTS5 SFR1 ATP2C1 BRCA1 TENM3 CLCNKA MCM3AP GMPR HSD3B2 ALCAM POLG2 | 4.67e-05 | 1219 | 138 | 20 | ctd:C023035 |
| Drug | trans-4-aminocrotonic acid | 5.43e-05 | 67 | 138 | 5 | CID000002766 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.10e-05 | 173 | 138 | 7 | 995_UP | |
| Drug | MS-8 | 1.39e-04 | 17 | 138 | 3 | CID002398714 | |
| Drug | dihydroxyaflavinine | 1.39e-04 | 17 | 138 | 3 | CID000156857 | |
| Drug | 6-thioguanine | 1.43e-04 | 130 | 138 | 6 | CID002723601 | |
| Drug | pentylenetetrazol | 1.43e-04 | 130 | 138 | 6 | CID000005917 | |
| Drug | thymol | 1.73e-04 | 46 | 138 | 4 | CID000006989 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | 1.74e-04 | 192 | 138 | 7 | 2572_UP | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 1.85e-04 | 194 | 138 | 7 | 6385_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.97e-04 | 196 | 138 | 7 | 2186_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.97e-04 | 196 | 138 | 7 | 7234_DN | |
| Drug | endosulfan | 1.99e-04 | 88 | 138 | 5 | CID000003224 | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.03e-04 | 197 | 138 | 7 | 4181_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.03e-04 | 197 | 138 | 7 | 5252_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.03e-04 | 197 | 138 | 7 | 7332_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A | 2.03e-04 | 197 | 138 | 7 | 3042_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; HL60; HT_HG-U133A | 2.03e-04 | 197 | 138 | 7 | 3007_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; HL60; HG-U133A | 2.03e-04 | 197 | 138 | 7 | 1371_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 138 | 7 | 3743_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 138 | 7 | 6129_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 138 | 7 | 7313_UP | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 199 | 138 | 7 | 5014_DN | |
| Drug | nitromethanamine | 2.17e-04 | 4 | 138 | 2 | CID000061148 | |
| Drug | 1-amino-8-nitropyrene | 2.17e-04 | 4 | 138 | 2 | CID000108113 | |
| Drug | methyl p-nitrobenzoate | 2.17e-04 | 4 | 138 | 2 | CID000012083 | |
| Drug | etizolam | 2.17e-04 | 4 | 138 | 2 | ctd:C044610 | |
| Drug | anilino acetate | 2.17e-04 | 4 | 138 | 2 | CID000153367 | |
| Drug | tert-butylbicyclo-2-benzoate | 2.17e-04 | 4 | 138 | 2 | ctd:C046308 | |
| Drug | c0458 | 2.17e-04 | 4 | 138 | 2 | CID009543178 | |
| Drug | Flunitrazepam | 2.67e-04 | 21 | 138 | 3 | ctd:D005445 | |
| Drug | honokiol | 2.79e-04 | 52 | 138 | 4 | ctd:C005499 | |
| Drug | imidazenil | 3.08e-04 | 22 | 138 | 3 | CID000119194 | |
| Disease | Liver carcinoma | A2M EPO KIF23 RCAN1 ACLY SPC25 ESM1 HPSE TERT IQGAP1 HSD3B2 SLC26A6 | 3.68e-06 | 507 | 134 | 12 | C2239176 |
| Disease | HSAN Type IV | 1.22e-04 | 4 | 134 | 2 | C0020074 | |
| Disease | Hereditary Sensory Radicular Neuropathy | 1.22e-04 | 4 | 134 | 2 | C0086405 | |
| Disease | Hereditary Sensory and Autonomic Neuropathies | 1.22e-04 | 4 | 134 | 2 | C0027889 | |
| Disease | Leukemia, Myelocytic, Acute | 1.44e-04 | 173 | 134 | 6 | C0023467 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 2.03e-04 | 5 | 134 | 2 | C0020072 | |
| Disease | Intellectual Disability | 2.13e-04 | 447 | 134 | 9 | C3714756 | |
| Disease | Sensory Neuropathy, Hereditary | 3.03e-04 | 6 | 134 | 2 | C0699739 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.03e-04 | 6 | 134 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | lifestyle measurement, anxiety disorder measurement | 4.14e-04 | 137 | 134 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.24e-04 | 7 | 134 | 2 | C0020075 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 5.63e-04 | 8 | 134 | 2 | C0020071 | |
| Disease | Heroin Dependence | 7.22e-04 | 9 | 134 | 2 | C0019337 | |
| Disease | Heroin Smoking | 7.22e-04 | 9 | 134 | 2 | C4505390 | |
| Disease | heroin abuse | 7.22e-04 | 9 | 134 | 2 | C0600241 | |
| Disease | testicular carcinoma | 8.00e-04 | 40 | 134 | 3 | EFO_0005088 | |
| Disease | triple-negative breast cancer | 8.99e-04 | 10 | 134 | 2 | EFO_0005537 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | Immature Reticulocyte Fraction Measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0009253 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.13e-03 | 45 | 134 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | obsolete aging, epigenetic status | 1.21e-03 | 46 | 134 | 3 | EFO_0000473, GO_0007568 | |
| Disease | Malignant neoplasm of breast | MICAL1 DYNC2H1 SLCO2B1 CTIF HPSE TERT PHKB ARFRP1 BRCA1 CLCA2 OTOF SPEN DNMT1 | 1.24e-03 | 1074 | 134 | 13 | C0006142 |
| Disease | Autistic Disorder | 1.26e-03 | 261 | 134 | 6 | C0004352 | |
| Disease | human papilloma virus infection, oropharynx cancer | 1.82e-03 | 53 | 134 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | Acute myeloid leukemia | 2.66e-03 | 17 | 134 | 2 | cv:C0023467 | |
| Disease | Alzheimer disease, psychotic symptoms | 2.66e-03 | 17 | 134 | 2 | EFO_0005940, MONDO_0004975 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.66e-03 | 17 | 134 | 2 | 601626 | |
| Disease | response to opioid | 2.72e-03 | 61 | 134 | 3 | EFO_0008541 | |
| Disease | ovarian carcinoma | 3.55e-03 | 321 | 134 | 6 | EFO_0001075 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.55e-03 | 67 | 134 | 3 | C3463824 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.77e-03 | 139 | 134 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | quinolinic acid measurement | 4.06e-03 | 21 | 134 | 2 | EFO_0010528 | |
| Disease | Nystagmus | 4.06e-03 | 21 | 134 | 2 | HP_0000639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDSSQKRYRAASAFF | 316 | O00154 | |
| DSSSRSKKNFYRNET | 1481 | Q68DN1 | |
| NASKRFQVVSYNTAS | 426 | Q6ZRH7 | |
| RFTYKFNFSKVVLVN | 116 | A0A1W2PQ73 | |
| LSNSVFTFSYKKAQR | 321 | P26439 | |
| ISRNDYAKFTQKIST | 626 | Q96N23 | |
| AEKNSYRRTVNTFSQ | 41 | Q8WY22 | |
| TIYQKAVSDRSFAFT | 416 | O43310 | |
| NSRTYSKFKNSLVVS | 1236 | P26358 | |
| RQFKAKDQTRFTAYL | 761 | Q9UNA0 | |
| LQFAYLDNFKTRTRS | 116 | Q8IWV2 | |
| KYSNMEQSLFTRFVR | 1111 | O60306 | |
| FQRNNKTVFKASSFA | 191 | Q13510 | |
| KRRQSSTQFSFVYLA | 216 | Q8TDJ6 | |
| SARQAFQAAKIITYK | 301 | P16066 | |
| YNNIKNFVRFQLSTS | 696 | P98194 | |
| FYNIKNFVRFQLSTS | 726 | O75185 | |
| LTAFVLKTFAQARAY | 1041 | P01023 | |
| SRRVGFYVNTFKNVS | 196 | P49418 | |
| KDTFFSNATRSRIVY | 296 | Q9BYT9 | |
| SQSYQKFRRFFQTAC | 1256 | P46940 | |
| QYFKSFKRVRINFSN | 101 | P53805 | |
| KTLTQVKTFFVSYRR | 361 | Q8IZ40 | |
| RNSDRKQAAAKFYSF | 511 | Q9H4I0 | |
| NEKIKYSRFAATNTR | 681 | Q96L73 | |
| YSRFAATNTRVKAKQ | 686 | Q96L73 | |
| FIYTLRNKQVKQAFS | 286 | Q9NZP2 | |
| RNTNRKQAAAKFYSF | 586 | O60216 | |
| FQRYFFQKLQSTSIK | 791 | Q9NVH2 | |
| QQAFFNYSTSKRITR | 141 | Q8WVV9 | |
| SKNSRQTVKVASVFY | 266 | Q8NGL3 | |
| TFFKAASSQLRALYS | 1486 | O94822 | |
| NLSYIKNFRFSSLAK | 331 | Q96NW4 | |
| ALNQLFRNSSIKSYF | 14356 | Q8WXI7 | |
| SYSRAKVKFNVNRVD | 151 | O00567 | |
| SFDITKFRSNKQYRI | 711 | O95461 | |
| FRAFSSFKNRVYLDT | 71 | P19256 | |
| NNSVFKQYFFETKCR | 166 | P01138 | |
| ITSNKKFFSLAATYR | 46 | Q9H7X0 | |
| AKSLYSRLFSFLVNT | 741 | Q9Y6X6 | |
| NFLRKSTQGISYSLF | 206 | Q6ZP29 | |
| LFYVAQTRQSNIFKI | 151 | Q8WXJ9 | |
| NFVRFFKLVQSASYL | 851 | O60318 | |
| ENTSKQYSLFKVTRA | 181 | Q9UGM5 | |
| FATSKVKSLFYSQVN | 1931 | Q5CZC0 | |
| SALIEFATVNYFTKR | 326 | P47869 | |
| FTAQDYRLQFRKCTS | 206 | Q8IUI8 | |
| KTVYNNNSSRFGKFV | 211 | Q9HD67 | |
| VARIYNQSFFQSLLK | 261 | Q8TDZ2 | |
| YDSFQLTENSFTRKK | 351 | Q9UHN1 | |
| SALIEFATVNYFTKR | 351 | P34903 | |
| SALIEFATVNYFTKR | 326 | P14867 | |
| DLTRSFSFRNSKQTY | 31 | Q9P2T1 | |
| KAFIRQNASFLYETV | 671 | Q8IYI6 | |
| ATRFKEQYRTFATAL | 226 | Q9BT25 | |
| SSKVIRTNNALYFAF | 316 | Q9NYM4 | |
| TIQTAFRQYQLSKNF | 321 | Q9UPP2 | |
| AFSYSFFVIRNAKVA | 526 | Q9Y251 | |
| KSNNESSFYAVKLAR | 486 | Q86UA1 | |
| QTFVKAIGRYSAFSQ | 206 | Q6UXL0 | |
| SSNYKKVDFFIRNSE | 1391 | A2PYH4 | |
| QSFFSRKDSIRTIYT | 81 | Q96MD2 | |
| REYLTAFTKNLVATF | 86 | O94913 | |
| FSYATERILKTFQIN | 281 | Q9Y5E2 | |
| YLQNTFKVSKRQSFA | 856 | P38398 | |
| YSSFVNLFRFNKERA | 46 | Q9Y2I7 | |
| ADVRKLFIFTTTQNY | 6 | Q8NCM8 | |
| VAVTSTNAAKIFNFY | 381 | O14531 | |
| VNTNTSYKAFSAARV | 81 | Q1HG44 | |
| TTFLEQSKTRFNKNY | 31 | Q13795 | |
| SQSRFLYVTFNKSIA | 481 | Q8NFZ0 | |
| TKDTQFSYAVFKSRV | 81 | Q969P0 | |
| KRSSAQTSQLTFKDY | 16 | Q9NZS2 | |
| LKNFVAFSRTDKYRQ | 176 | Q53GT1 | |
| RNFFKAQLYTTNTVK | 191 | P54132 | |
| RNNFDYTGKKSFVRT | 1506 | Q9BZ29 | |
| FRSLYKSVFEQSLSQ | 296 | Q9UPW0 | |
| TADTFRKLFRVYSNF | 161 | P01588 | |
| SLAYSSVQDVQKFAR | 161 | Q9NX46 | |
| QRKQSERKFYFDSST | 1111 | Q9UHN6 | |
| VEACFKQFKTQYSTR | 191 | P48664 | |
| NSTANYDFVLKKRTF | 871 | Q12967 | |
| KFPFFQYSVTKSSNR | 131 | Q9NQ30 | |
| TYAEISQAFSKRNKA | 506 | Q9NRM0 | |
| AKSSIQFYNKVISSR | 951 | Q86Z14 | |
| VTFNNQRSYLKAVSA | 476 | Q9BZB8 | |
| VTTSQSQYFSFREKI | 316 | Q8IYT3 | |
| DFQRKIRQSYFASVS | 291 | P22304 | |
| DLERTFTFRNSKQTY | 31 | P36959 | |
| VFIAFRSSTKKSVQY | 66 | Q13740 | |
| FQSKSFVRLKDVTAY | 2746 | Q8TDX9 | |
| FKSRVRLYSQSQSFQ | 266 | Q7L3B6 | |
| AVRYGAAFTQKFSSS | 781 | Q93100 | |
| KKSERYDFFAQQTRF | 331 | Q8N108 | |
| AKVTFRGQSFYSRVL | 21 | Q9HC10 | |
| SFQLQEKSYNFRTAT | 286 | O15547 | |
| IYATFQFTFRKSNSL | 156 | Q8NGT5 | |
| FQAKRYVFKSNDRNS | 146 | Q02241 | |
| ATTSIKSFFRQLNLY | 146 | Q9UBD0 | |
| SQFSQALAIRSYTKF | 301 | Q9NZJ7 | |
| AFKTLFVARVNYDTT | 101 | P08621 | |
| QRVSIFFDYARCSKN | 106 | Q9UI12 | |
| NYSESQKTVTFARKL | 566 | Q4G0N8 | |
| SLQARVESFFTYKTR | 76 | Q8N3T6 | |
| KNARATNRTNFAITY | 161 | Q96NR3 | |
| KVFRSSATVYFANAE | 541 | Q9BXS9 | |
| LQRKQLYSFFTSSGS | 626 | Q6ZNJ1 | |
| STARADYFAQKQRKL | 491 | Q9BPZ7 | |
| KSLFFYQKARTFATE | 1296 | Q8TE82 | |
| FTTAYFKQQTIRELF | 2196 | Q6ZRS2 | |
| RKTRFSFNSSYNVVK | 56 | Q86XK3 | |
| TKYKSFVQTARLVFR | 266 | Q9BSK2 | |
| LFEYKFVNSRLINST | 561 | Q7L0J3 | |
| NFSAFLANVRKAFTA | 206 | Q9HBM1 | |
| YKFICTTSAIQNRFK | 16 | P53396 | |
| TTSAIQNRFKYARVT | 21 | P53396 | |
| TEASFYLFNATKRRV | 66 | Q9UQC9 | |
| FCQRTFLSFIKTNRY | 301 | P51800 | |
| RQFAVLADTSFNYIK | 466 | Q8IYJ2 | |
| ETFRNAKVANLYKAS | 586 | O94762 | |
| VSYRQVAFDFTKVKR | 136 | Q13492 | |
| YLFRSFKATKFFQST | 471 | Q6P2Q9 | |
| FKDKFRRLQNSYTAS | 91 | Q5JTD0 | |
| AFFTNRYVKARTELT | 676 | Q96T68 | |
| VFRQKFRQFSYSDST | 46 | Q86W11 | |
| RQFSQASDYFSKALK | 396 | Q86TZ1 | |
| RLSSSLERNKFYSFA | 1421 | Q96T58 | |
| FVNVNRKASTASDVY | 191 | Q9Y572 | |
| TNRASAYFRLKKFAV | 171 | Q9H6T3 | |
| KFLERQFSITASYAN | 396 | O94956 | |
| NSKAAFQASTRVYFE | 71 | A6NFA1 | |
| TIHTNSSLRNYFVKF | 51 | Q96R05 | |
| QQAAKSFYDRISFLI | 831 | Q9P273 | |
| FEFSAQKNRSYVISS | 561 | Q00722 | |
| RTVFKFYQSSNKRLN | 751 | O60290 | |
| FVATANRKATSAVYK | 341 | Q8WU66 | |
| RYFFKSTVLASVQRG | 951 | Q96QU8 | |
| NFYLKSVFIKQQRFA | 166 | Q96LW1 | |
| AIQTFCYQKTFSTRI | 116 | Q7Z769 | |
| TTFQKNRLFFYRKSV | 566 | O14746 | |
| KGYRFIFLTTAVTNS | 591 | Q9H267 | |
| NFSSSVNSKFKVRNF | 116 | Q9C0D4 |